Highstreet Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Highstreet Asset Management’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$1K	Hold	11	–	–	﹤0.01%	633
2019 Q3	$1K	Hold	11	–	–	﹤0.01%	400
2019 Q2	$1K	Sell	11 -13	-54%	-$957	﹤0.01%	400
2019 Q1	$2K	Hold	24	–	–	﹤0.01%	363
2018 Q4	$2K	Hold	24	–	–	﹤0.01%	346
2018 Q3	$4K	Buy	+24	New	+$3.62K	﹤0.01%	281

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Highstreet Asset Management's LGND Position: Q4 2019 in Review

Highstreet Asset Management held its Ligand Pharmaceuticals (LGND) position steady in Q4 2019 at 11 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #633.

Highstreet Asset Management first reported a position in LGND in Q3 2018 and has held it in 6 quarters since. The position peaked at $4K in Q3 2018. 266 funds tracked by Wall St. Rank hold LGND as of Q4 2019.

Highstreet Asset Management held 11 shares of Ligand Pharmaceuticals worth $1K as of Q4 2019.
Highstreet Asset Management left its Ligand Pharmaceuticals share count unchanged in Q4 2019.
Ligand Pharmaceuticals made up ﹤0.01% of Highstreet Asset Management's portfolio in Q4 2019, its #633 holding.
Highstreet Asset Management first reported a position in Ligand Pharmaceuticals in Q3 2018 and has held it in 6 quarters since.
Highstreet Asset Management's Ligand Pharmaceuticals position peaked at $4K in Q3 2018.
266 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2019.

Based on Highstreet Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.